As such, tirzepatide holds promise as a potential therapeutic option for individuals struggling with obesity and its associated health complications, providing new hope in the ongoing battle against the global epidemic of obesity.
The medication does not differentiate between burning adipose tissue (fat) and muscle fibers
In adults who lose 15% of body weight on a GLP-1 drug, that figure means a meaningful absolute reduction in muscle mass for a patient who may already be near the threshold of sarcopenia
Many patients begin to notice a reduction in appetite within the first week of starting semaglutide
Ozempic has become the byword for semaglutide and similar drugs that cause weight loss, regardless of which brand a person is taking or why, and there have even been shortages of the drugs as people clamour to get their hands on them
P., Burman, D., Tannock, I